Leelyn Smith, LLC Amgen Inc Transaction History

Leelyn Smith, LLC

$516 Million
Q2 2024

A detailed history of Leelyn Smith, LLC transactions in Amgen Inc stock. As of the latest transaction made, Leelyn Smith, LLC holds 9,015 shares of AMGN stock, worth $2.85 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

9,015

Previous 9,304 3.11%

Holding current value

$2.85 Million

Previous $2.65 Million 6.47%

% of portfolio

0.55%

Previous 0.53%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $75,934 - $92,280	-289 Reduced 3.11%	9,015 $2.82 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $48,665 - $58,745	-181 Reduced 1.91%	9,304 $2.65 Million
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $198,934 - $224,421	-778 Reduced 7.58%	9,485 $2.73 Million
Q3 2023 Nov 06, 2023	SELL	$218.65 - $271.46 $68,218 - $84,695	-312 Reduced 2.95%	10,263 $2.76 Million
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $89,564 - $105,908	-418 Reduced 3.8%	10,575 $2.35 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $2.46 Million - $3 Million	10,883 Added 9893.64%	10,993 $2.66 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $10,998 - $12,404	49 Added 80.33%	110 $25,000
Q2 2021 Aug 31, 2021	SELL	$233.58 - $259.14 $7,007 - $7,774	-30 Reduced 32.97%	61 $15,000
Q1 2021 May 05, 2021	BUY	$221.91 - $258.6 $11,317 - $13,188	51 Added 127.5%	91 $23,000
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $3,462 - $4,122	-16 Reduced 28.57%	40 $9,000
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $234 - $260	-1 Reduced 1.75%	56 $7.63 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $5,934 - $7,282	30 Added 111.11%	57 $13,000
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $364 - $483	-2 Reduced 6.9%	27 $5,000
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $5,487 - $7,052	29 New	29 $7,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leelyn Smith, LLC with notifications on news.

Account